Display options
Share it on

J Diabetes Sci Technol. 2007 Jan;1(1):18-27. doi: 10.1177/193229680700100104.

Immobilization techniques to avoid enzyme loss from oxidase-based biosensors: a one-year study.

Journal of diabetes science and technology

Jody L House, Ellen M Anderson, W Kenneth Ward

Affiliations

  1. iSense Development Corporation , Portland, Oregon 97224, USA. [email protected]

PMID: 19888375 PMCID: PMC2769612 DOI: 10.1177/193229680700100104

Abstract

BACKGROUND: Continuous amperometric sensors that measure glucose or lactate require a stable sensitivity, and glutaraldehyde crosslinking has been used widely to avoid enzyme loss. Nonetheless, little data is published on the effectiveness of enzyme immobilization with glutaraldehyde.

METHODS: A combination of electrochemical testing and spectrophotometric assays was used to study the relationship between enzyme shedding and the fabrication procedure. In addition, we studied the relationship between the glutaraldehyde concentration and sensor performance over a period of one year.

RESULTS: The enzyme immobilization process by glutaraldehyde crosslinking to glucose oxidase appears to require at least 24-hours at room temperature to reach completion. In addition, excess free glucose oxidase can be removed by soaking sensors in purified water for 20 minutes. Even with the addition of these steps, however, it appears that there is some free glucose oxidase entrapped within the enzyme layer which contributes to a decline in sensitivity over time. Although it reduces the ultimate sensitivity (probably via a change in the enzyme's natural conformation), glutaraldehyde concentration in the enzyme layer can be increased in order to minimize this instability.

CONCLUSIONS: After exposure of oxidase enzymes to glutaraldehyde, effective crosslinking requires a rinse step and a 24-hour incubation step. In order to minimize the loss of sensor sensitivity over time, the glutaraldehyde concentration can be increased.

Keywords: biosensor; glucose; glucose oxidase; glutaraldehyde; lactate oxidase

References

  1. Diabetes Technol Ther. 2000 Autumn;2(3):367-76 - PubMed
  2. Diabetes Technol Ther. 2000 Autumn;2(3):473-7 - PubMed
  3. Scand J Clin Lab Invest. 1960;12(4):402-7 - PubMed
  4. Occup Environ Med. 2000 Mar;57(3):165-74 - PubMed
  5. Biosens Bioelectron. 2002 Oct;17(10):851-7 - PubMed
  6. Lancet. 1957 Aug 24;273(6991):368-70 - PubMed
  7. Biomaterials. 1994 Aug;15(10):859-64 - PubMed
  8. Front Biosci. 2005 Jan 01;10:512-20 - PubMed
  9. Biosens Bioelectron. 2002 Mar;17(3):181-9 - PubMed
  10. Diabetes Technol Ther. 2004 Jun;6(3):389-401 - PubMed
  11. Horm Metab Res. 1994 Nov;26(11):534-7 - PubMed
  12. Bioconjug Chem. 2005 Nov-Dec;16(6):1451-8 - PubMed
  13. Anal Biochem. 1997 Nov 15;253(2):162-8 - PubMed
  14. N Engl J Med. 2001 Nov 8;345(19):1359-67 - PubMed
  15. Occup Med (Lond). 2003 Mar;53(2):139-42 - PubMed
  16. J Mol Biol. 1972 Apr 14;65(3):525-9 - PubMed
  17. J Strength Cond Res. 2002 Feb;16(1):38-43 - PubMed
  18. Prog Med Chem. 1976;13:271-301 - PubMed
  19. Clin Chem. 1961 Oct;7:542-5 - PubMed
  20. Occup Med (Lond). 2000 Jul;50(5):334-6 - PubMed
  21. J Biotechnol. 2006 Jan 24;121(2):284-9 - PubMed

Publication Types